Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of ¥134.00 per share. This is a 20.72 percent increase over earnings of ¥111.00 per share from the same period last year. The company reported quarterly sales of ¥1.176 trillion which beat the analyst consensus estimate of ¥1.084 trillion by 8.48 percent. This is a 12.75 percent increase over sales of ¥1.043 trillion the same period last year.
Takeda Pharmaceutical Q2 2024 GAAP EPS ¥134.00 Up From ¥111.00 YoY, Sales ¥.176T Beat ¥1.084T Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated